Results 101 to 110 of about 267,865 (313)

Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients [PDF]

, 2014
BACKGROUND AND PURPOSE Treatment with statins reduces the rate of cardiovascular events in high-risk patients, but residual risk persists. At least part of that risk may be attributable to atherogenic dyslipidemia characterized by low high-density ...
Sirimarco, Gaia, Labreuche, Julien, Fox, Kim M, Amarenco, Pierre, Bruckert, Eric, Goldstein, Larry B, Rothwell, Peter M, Mattle, Heinrich P   +7 more
core   +1 more source

Navigating Asparaginase Treatment for Patients With Acute Lymphoblastic Leukemia: US Consensus Panel Recommendations on the Role of Multidisciplinary Care

American Journal of Hematology, EarlyView.
ABSTRACT Asparaginase is a critical treatment component for patients with acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL). However, the successful delivery of asparaginase‐based therapy remains challenging across care settings due to its complex administration, distinct toxicity profile, prolonged treatment duration, and the need for ...
Amir Ali, Grace Elsey, Kayla Fulginiti, Zanette Kanani‐Bradley, Holly R. Kubaney, Sandra Kurtin, Theresa Nguyen, Jennifer Turchina, Charlotte B. Wagner   +8 more
wiley   +1 more source

Cross-sectional study of pattern of Dyslipidemia and Prevalence of Atherogenic Diabetic Dyslipidemia in newly detected Diabetic patients

Asian Journal of Medical Sciences, 2019
Background: India has seen an ever increasing number of diabetic patients and in turn rise in cardiovascular diseases. Many studies have shown diabetic patients to have dyslipidemia, with certain common patterns early in the disease.
Vinay Krishnamurthy , Akhila Rao Kerekoppa , Prabhakar B   +2 more
doaj   +1 more source

Dyslipidemia [PDF]

Canadian Journal of Diabetes, 2013
G B John, Mancini, Robert A, Hegele, Lawrence A, Leiter   +2 more
openaire   +4 more sources

Dyslipidemia and Atherosclerosis

, 2017
Dyslipidemia and atherosclerosis are met in the concept of atherogenic dyslipidemia that has ....
Setianto, B
core   +1 more source

Frequency of dyslipidemia and isolated and mixed dyslipidemia in HIV infected patients in Asmara, Eritrea.

, 2022
Frequency of dyslipidemia and isolated and mixed dyslipidemia in HIV infected patients in Asmara, Eritrea.
Oliver Okoth Achila (7861130), Yafet Kesete (12988216), Feven Tesfaldet (12988219), Filmon Alazar (12988222), Feven Abrhaley (12988213), Danait Andemichael (12988234), Lidya Gebremeskel (12988228), Rodas Mehari (12988231), Lidya Fisshaye (12988225)   +8 more
core   +1 more source

The liver‐brain axis: A multidimensional regulatory network implicated in Alzheimer's disease pathogenesis and clinical implications

Animal Models and Experimental Medicine, EarlyView.
Schematic diagram of the core pathways of the liver‐brain axis in regulating AD. The liver regulates cerebral Aβ deposition, tau phosphorylation, and neuroinflammation through pathways such as metabolic detoxification (urea cycle, ketone body metabolism, glutathione antioxidant system), molecular secretion (APOE, CRP, FGF21, IGF‐1), and Aβ clearance ...
Ning Zhang, Wei Chen, Meng Wang
wiley   +1 more source

Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes

BMC Research Notes, 2017
Background Atherogenic dyslipidemia is an important modifiable risk factor for cardiovascular disease among patients of type 2 diabetes mellitus.
Daya Ram Pokharel, Dipendra Khadka, Manoj Sigdel, Naval Kishor Yadav, Shreedhar Acharya, Ramchandra Kafle, Ravindra Mohan Sapkota, Tara Sigdel   +7 more
doaj   +1 more source

The Association Between Chronological Age and Dyslipidemia: A Cross-Sectional Study in Chinese Aged Population

, 2023
Qingyao Li,1,2,* Ying Jiang,2,* Anqi Song,2 Yun Li,1 Xinyi Xu,3 Renying Xu2 1Department of Preventive Medicine, School of Public Health, North China University of Science and Technology, Tangshan, People’s Republic of China; 2Department of ...
Jiang Y, Li Y, Xu R, Song A, Li Q, Xu X
core  

Factors associated with dyslipidemia.

, 2022
Factors associated with dyslipidemia.
Wonseok Jeong (5777678)
core   +1 more source